Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.

Psychiatry and clinical neurosciences - 1 Oct 2005

Himei Akio, Okamura Takehiko

Abstract excerpt

The present study used a diversified approach to the evaluation of the clinical efficacy of the atypical antipsychotic risperidone, and the most appropriate method of switching the medication of patients undergoing alternative therapies; particularly, the widely used typical antipsychotic haloperidol. A study group of 120 patients with CYP2D6*1/*1 was subdivided into an untreated group of 20 (group A) and two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Haloperidol

Share to Muscarinic Antagonists

Share to Psychiatric Status Rating Scales

Share to Risperidone

Share to Schizophrenic Psychology

Source

Identifiers

PMID: 16194258
DOI: 10.1111/j.1440-1819.2005.01414.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.PMID 16194258Read ↗

Into a Deeper Understanding of CYP2D6's Role in Risperidone Monotherapy and the Potential Side Effects in Schizophrenia Spectrum Disorders.Semantic proximity Read ↗

Cytochrome P450 2D6 Poor Metabolizers and Risperidone Treatment Failure: A 1-Year Longitudinal Study.Semantic proximity Read ↗

Risperidone plasma levels, clinical response and side-effects.Semantic proximity Read ↗

A population pharmacokinetic evaluation of the influence of CYP2D6 genotype on risperidone metabolism in patients with acute episode of schizophrenia.Semantic proximity Read ↗

Behavioural effects of chronic haloperidol and risperidone treatment in rats.Semantic proximity Read ↗

Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.Semantic proximity Read ↗

Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.Semantic proximity Read ↗

“The Efficacy and Safety of Aripiprazole and Paliperidone 1 and 3-Month Long-Acting Preparations During The Maintenance of Schizophrenia in Clinical Practice”Semantic proximity Read ↗

Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients.Semantic proximity Read ↗

Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors.Semantic proximity Read ↗

Antipsychotic Selection in Combination with Electroconvulsive Therapy for Acute Schizophrenia: Differential Efficacy and Safety Profiles from a Real World StudySemantic proximity Read ↗

Real-World Outcomes of Lurasidone Augmentation for Treatment-Resistant Bipolar Depression: A Retrospective Observational AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.